Otrivin Uten Konserveringsmiddel Med Mentol (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivin Uten Konserveringsmiddel Med Mentol, is an alpha‑adrenergic agonist nasal decongestant presented as a nasal spray solution for intranasal use. It provides temporary relief of nasal congestion associated with colds, sinusitis and allergic rhinitis.

GNH USA supplies Otrivin Uten Konserveringsmiddel Med Mentol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Customers benefit from reliable lead times and comprehensive technical support.

Xylometazoline acts on the nasal mucosa to relieve congestion by constricting blood vessels.

- Common cold: reduces nasal blockage for faster breathing - Allergic rhinitis: alleviates congestion caused by allergens - Acute sinusitis: eases swelling of nasal passages during infection - Upper respiratory tract infection: provides temporary decongestion - Nasal congestion after air travel: improves airflow

Adverse reactions may occur with intranasal use of xylometazoline.

Common Side Effects: - Burning sensation in the nose - Nasal dryness - Sneezing - Transient headache

Serious or Rare Side Effects: - Severe hypertension - Cardiac arrhythmia - Nasal ulceration

Before using Otrivin Uten, consider the following safety measures.

- Age restriction: avoid use in children under 6 years - Duration limit: do not exceed 3 consecutive days of treatment - Pre-existing hypertension: use with caution and monitor blood pressure - Pregnancy and lactation: consult a healthcare professional before use - Concurrent use of other nasal decongestants: avoid to prevent excess vasoconstriction - Store at room temperature: keep in the original container, protect from moisture and direct sunlight

Xylometazoline may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis - Other topical nasal decongestants: additive sympathomimetic effects

Moderate Interactions (Monitor Closely):\n- Antihypertensive agents: may reduce blood pressure control - Beta‑blockers: potential for increased cardiovascular effects - Tricyclic antidepressants: may enhance sympathomimetic activity